Biotech grants in Sweden
Explore Biotech grants for companies in Sweden. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Swedish innovation agencies, research funders and foundations, EU and international programs open to applicants in Sweden, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Sweden come first.
Showing 361-384 of 654 grants
Cellular and Molecular Biology of Complex Brain Disorders (R21)
NIH · United States
Funds short, exploratory work on what genetic risk factors for brain disorders actually do inside cells and circuits.
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access
NIH · United States
Funds access to NIH's genotyping and sequencing lab, not a cash award, for research that needs large-scale genetic data.
Challenge Programme — AMR Diagnostics for LRTI
NNF · Denmark
Supports diagnostic innovations for antimicrobial resistant respiratory infections in Danish consortia.
Challenge Programme — Heat and Hypertension
NNF · Denmark
Supports large Danish research teams studying heat stress impacts on hypertension outcomes.
Cure SMA Basic Research Grant
Cure SMA · United States
Funds novel research on spinal muscular atrophy biology and drug target identification worldwide.
Deep Tech Geeks Startups Competition
Deep Tech MEA · United Arab Emirates
Awards a free exhibition pod, travel and mentorship to deep-tech scale-ups that place in this annual competition at GITEX North Star in Dubai.
Deep Tech Startup Pitch Competition
Deep Tech Atelier · Latvia
Lets early-stage deep tech founders worldwide pitch investors live for partner prizes in Riga.
Diana Davis Spencer Clinical Research Fellowship Award
FFB · United States
Supports physicians entering inherited retinal degeneration subspecialty training to build clinician-scientists for vision-preserving therapies.
Drug Development Project
CRUK · United Kingdom
Sponsors and directly runs cancer drug development, in place of a cash grant.
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies
NIH · United States
Funds research into what is driving more non-hereditary cancers in 18-to-49-year-olds, and how to catch them earlier.
Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases
NIH · United States
Funds the continued operation and improvement of an already-established biomedical data repository or knowledgebase with a track record of impact.
Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets
NIH · United States
Funds rigorous preclinical validation and early drug discovery against novel Alzheimer's and related-dementia targets, before human trials.
FSHD Bonus Prize
XPRIZE · United States
Pays teams from a $10 million purse for therapeutics that measurably improve muscle function in people with facioscapulohumeral muscular dystrophy, run as a track alongside the main XPRIZE Healthspan competition.
Gates Foundation Grand Challenges — Portfolio
Gates Foundation · United States
Supports global health innovators through rotating challenge themes in diagnostics, nutrition, and development-focused technologies for public impact.
INCITE — Proposals
DOE SC · United States
Supports allocation of exascale compute resources for scientific codes and high-impact computing studies.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
NIH · United States
Funds developing an assay and screening to identify a therapeutic agent, ahead of characterisation and efficacy testing on it.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Therapeutic Agent Characterization and Preclinical Efficacy Studies
NIH · United States
Funds pharmacodynamic, pharmacokinetic and efficacy testing that shows a therapeutic agent has enough biological activity to justify further development.
International Innovation Grant
Conquer Cancer · Global / Multinational
Funds global oncology innovation programs in low-resource partner institutions to strengthen real-world implementation.
LifeArc Early Ventures
🇬🇧LifeArc · United Kingdom
Funds early-stage life science ventures with seed and Series A equity across therapeutics and medical device innovation.
LifeArc Rare Disease Clinical Trials Programme
🇬🇧LifeArc · United Kingdom
Supports clinical rare-disease teams with practical trial design and execution.
Long-term International Fellowship
Conquer Cancer · Global / Multinational
Funds oncologists from lower-income settings through long-term international fellowships to strengthen real-world implementation.
LRA-Genentech Award on Immune Resetting Therapies for Lupus
🇺🇸LRA · United States
Helps yr for pilot or mechanistic immune resetting research in lupus co-funded through the LRAGenentech Award on Immune Resetting Therapies for.
Minnesota Angel Tax Credit
🇺🇸MN DEED · United States
Funds Minnesota angel investors through a refundable credit for investments in high-technology startups.
MJFF Targets to Therapies: Mitochondrial Target Validation
MJFF · United States
Supports mitochondrial target validation in Parkinson's research to build stronger therapy-ready evidence.